- Report
- August 2021
- 217 Pages
Global
From €5926EUR$6,168USD£5,067GBP
- Report
- May 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,928GBP
- Report
- March 2022
- 124 Pages
Global
From €4324EUR$4,500USD£3,697GBP
- Book
- June 2015
- 392 Pages
- Book
- March 2023
North America
- Book
- October 2012
- 1570 Pages
The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more